Agenda

8:00 AM – 9:00 AM

Non-CME Innovation Theater
9:00 AM – 9:05 AM

Movement Break
9:05 AM – 9:10 AM

Welcome
9:10 AM – 9:55 AM
Plenary 1: Diagnostic Biomarkers Testing/Liquid Biopsies
- Presenter
  - Andrew McKenzie
- Room:
  - Astor Ballroom
9:55 AM – 10:05 AM

Movement Break
10:05 AM – 10:35 AM
Session 1: Navigating the Evolving Treatment Landscape for EGFR-Mutated Non-Small Cell Lung Cancer
- Room:
  - Duffy/Columbia
10:05 AM – 10:35 AM
Session 1: Selected Topic in Gastrointestinal Cancers
- Room:
  - Astor Ballroom
10:05 AM – 10:35 AM
Session 1: Selected Topic in Women's Cancers
- Room:
  - Chelsea/Hudson
+

10:35 AM – 11:20 AM
Session 2: Debate: CTLA-4 Inhibition in Lung Cancer: The Time is Now or Never? Now vs Never
- Room:
  - Duffy/Columbia
- 10:35 AM – 10:55 AM
  CTLA-4 Inhibition in Lung Cancer: The Time is Now or Never? Now
- 10:55 AM – 11:15 AM
  CTLA-4 Inhibition in Lung Cancer: The Time is Now or Never? Never
+

10:35 AM – 11:20 AM
Session 2: Debate: Antibody Drug Conjugates: Should We Use Sequentially? Yes, They Are Better than Chemo vs No, the Benefit is Really Just for the First ADC
- Room:
  - Chelsea/Hudson
- 10:35 AM – 10:55 AM
  Antibody Drug Conjugates: Should We Use Sequentially? Yes, They Are Better than Chemo
- 10:55 AM – 11:15 AM
  Antibody Drug Conjugates: Should We Use Sequentially? No, the Benefit is Really Just for the First ADC

Available Dates